Accuray
Open
$0.47
Prev. Close
$0.47
High
$0.47
Low
$0.46
Market Snapshot
$47.8M
-1.3
-0.04
$453.14M
990
Accuray, Inc. is a radiation therapy company, which engages in manufacturing medical equipment. The company is headquartered in Madison, Wisconsin and currently employs 990 full-time employees. The company went IPO on 2007-02-08. The firm develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.
emptyResult
Accuray, Inc. is a radiation therapy company, which engages in manufacturing medical equipment. The company is headquartered in Madison, Wisconsin and currently employs 990 full-time employees. The company went IPO on 2007-02-08. The firm develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.
Recently from Cashu
Accuray Appoints Paul Miele as Senior VP and Chief Commercial Officer
Accuray Incorporated announces the appointment of Paul Miele as Senior Vice President and Chief Commercial Officer, effective April 6, 2026. This strategic decision aims to bolster the company's comme…
Accuray Innovates Precision Radiation Therapy with Advanced Technologies and Collaboration
Accuray Advances Precision Radiation Therapy with New Technological Developments Accuray Incorporated continues to solidify its position in the radiation oncology landscape with the introduction of in…
Accuray's Leadership Change and Strategy Amid Financial Decline and Innovation Focus
Accuray's Leadership Shift and Strategic Developments Amidst Financial Challenges Accuray Incorporated faces a challenging financial landscape as it reports a 7% decline in total net revenue for the f…
Accuray Faces Leadership Change Amid Declining Q1 Financial Performance and Strategic Initiatives
Accuray Navigates Leadership Change Amidst Challenging Q1 Financial Results Accuray Incorporated, a leader in innovative radiation oncology solutions, reports its financial results for the first quart…